SEC Form 4 · accession 0001226488-16-000004

MYRIAD GENETICS INC · MYGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 9, 2016

Accepted (ET)

Sep 13, 2016 · 10:38 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000899923

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 9, 2016	M	27,993	$10.60	A	49,493	D
Common Stock	Sep 9, 2016	S	27,993	$20.514	D	21,500	D
Common Stock	Sep 12, 2016	M	2,007	$10.60	A	23,507	D
Common Stock	Sep 12, 2016	S	2,007	$20.2132	D	21,500	D
Common Stock	holding	—	—		—	300	I	by Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F1	$10.60	Sep 9, 2016	M	27,993	D	—	Nov 16, 2016	Common Stock	27,993	2,007	D
Non-Qualified Stock Option (right to buy)^F1	$10.60	Sep 12, 2016	M	2,007	D	—	Nov 16, 2016	Common Stock	2,007	0	D